REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,049,286 | +23.6% | 3,325,480 | +19.5% | 0.46% | +19.1% |
| Q2 2023 | $74,458,090 | +4.7% | 2,783,480 | -15.2% | 0.39% | -1.5% |
| Q1 2023 | $71,122,776 | +75.8% | 3,283,600 | +93.4% | 0.39% | +63.1% |
| Q4 2022 | $40,446,717 | -18.0% | 1,698,015 | -32.1% | 0.24% | -11.7% |
| Q3 2022 | $49,300,000 | -22.2% | 2,500,000 | -23.1% | 0.27% | -21.1% |
| Q2 2022 | $63,343,000 | -23.6% | 3,250,000 | 0.0% | 0.35% | -13.5% |
| Q1 2022 | $82,908,000 | +19.8% | 3,250,000 | +18.2% | 0.40% | +15.6% |
| Q4 2021 | $69,218,000 | -8.5% | 2,750,000 | 0.0% | 0.35% | -2.0% |
| Q3 2021 | $75,653,000 | -4.7% | 2,750,000 | +10.0% | 0.35% | +9.0% |
| Q2 2021 | $79,350,000 | +7.4% | 2,500,000 | +55.3% | 0.32% | -11.7% |
| Q1 2021 | $73,854,000 | +16167.4% | 1,609,730 | +7664.1% | 0.37% | +9075.0% |
| Q1 2020 | $454,000 | – | 20,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |